| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer
|
Nakajo, Akihiro
|
|
2008
|
62 |
6 |
p. 1103-1109
|
artikel
|
| 2 |
BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR
|
Kang, Hyo Jin
|
|
2008
|
62 |
6 |
p. 965-975
|
artikel
|
| 3 |
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms
|
Font, Albert
|
|
2008
|
62 |
6 |
p. 1075-1083
|
artikel
|
| 4 |
Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines
|
Liang, Xing-Jie
|
|
2008
|
62 |
6 |
p. 977-984
|
artikel
|
| 5 |
Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo
|
Mauritz, Robert
|
|
2008
|
62 |
6 |
p. 937-948
|
artikel
|
| 6 |
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL™), a multi-targeted kinase inhibitor
|
Luo, Feng (Roger)
|
|
2008
|
62 |
6 |
p. 1065-1074
|
artikel
|
| 7 |
Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell
|
Wei, San-Hua
|
|
2008
|
62 |
6 |
p. 1055-1064
|
artikel
|
| 8 |
Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion
|
Xie, Zhigang
|
|
2008
|
62 |
6 |
p. 949-957
|
artikel
|
| 9 |
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity
|
Callizot, Noelle
|
|
2008
|
62 |
6 |
p. 995-1007
|
artikel
|
| 10 |
Is oncogenesis a normal cellular defense mechanism?
|
Sorscher, Steven
|
|
2008
|
62 |
6 |
p. 1113
|
artikel
|
| 11 |
Non-invasive MRI tumor imaging and synergistic anticancer effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenic pancreatic tumor model
|
Cao, Xianhua
|
|
2008
|
62 |
6 |
p. 985-994
|
artikel
|
| 12 |
Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo
|
O’Reilly, Terence
|
|
2008
|
62 |
6 |
p. 1045-1054
|
artikel
|
| 13 |
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group
|
Thompson, Patrick A.
|
|
2008
|
62 |
6 |
p. 1027-1037
|
artikel
|
| 14 |
Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer
|
Ruiz, M.
|
|
2008
|
62 |
6 |
p. 1085-1090
|
artikel
|
| 15 |
Professor Lloyd R. Kelland: man of science
|
Newell, Herbie
|
|
2008
|
62 |
6 |
p. 1115-1116
|
artikel
|
| 16 |
Professor Lloyd R. Kelland: man of science
|
Newell, Herbie
|
|
|
62 |
6 |
p. 1115-1116
|
artikel
|
| 17 |
Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae
|
Huang, Min
|
|
2008
|
62 |
6 |
p. 1015-1026
|
artikel
|
| 18 |
Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer
|
Park, Se Hoon
|
|
2008
|
62 |
6 |
p. 1009-1014
|
artikel
|
| 19 |
Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy
|
Nagai, Hidenari
|
|
2008
|
62 |
6 |
p. 959-963
|
artikel
|
| 20 |
Topotecan distribution in an anephric infant with therapy resistant bilateral Wilms tumor with a novel germline WT1 gene mutation
|
Lugtenberg, Rieneke T.
|
|
2008
|
62 |
6 |
p. 1039-1044
|
artikel
|
| 21 |
Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion
|
Brown, Alan P.
|
|
2008
|
62 |
6 |
p. 1091-1101
|
artikel
|
| 22 |
Tumor resensitization to erlotinib following brief substitution of cetuximab
|
Epstein, R. J.
|
|
2008
|
62 |
6 |
p. 1111-1112
|
artikel
|
| 23 |
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study
|
François, Eric
|
|
2008
|
62 |
6 |
p. 931-936
|
artikel
|
Tijdschrift beschrijving